参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Cao W,Chen HD,Yu YW,et al.Changing profiles of cancer burden worldwide and in China:a secondary analysis of the global cancer statistics 2020[J].Chin Med J (Engl),2021,134(7):783-791.[3]Xia C,Dong X,Li H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J (Engl),2022,135(5):584-590.[4]Kanth P,Inadomi JM.Screening and prevention of colorectal cancer[J].BMJ,2021,374:n1855.[5]Yu K,Qiang G,Peng S,et al.Potential diagnostic value of the hematological parameters lymphocyte-monocyte ratio and hemoglobin-platelet ratio for detecting colon cancer[J]. J Int Med Res,2022,50(9):3000605221122742.[6]Khandia R,Munjal A.Interplay between inflammation and cancer[J].Adv Protein Chem Struct Biol,2020,119:199-245.[7]Arbogast F,Gros F.Lymphocyte Autophagy in Homeostasis,Activation,and Inflammatory Diseases[J].Front Immunol,2018,9:1801.[8]Franco AT,Corken A,Ware J.Platelets at the interface of thrombosis,inflammation,and cancer[J].Blood,2015,126(5):582-588.[9]He Y,Liu C,Zeng Z,et al.Red blood cell distribution width:a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis[J].Clin Rheumatol,2018,37(1):161-167.[10]Diem S,Schmid S,Krapf M,et al.Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab[J].Lung Cancer,2017,111:176-181.[11]Hannarici Z,Yilmaz A,Buyukbayram ME,et al.A novel prognostic biomarker for cutaneous malignant melanoma:red cell distribution width (RDW) to lymphocyte ratio[J].Melanoma Research,2021,31(6):566-574.[12]Liao DW,Hu X,Wang Y,et al.C-reactive Protein Is a Predictor of Prognosis of Prostate Cancer:A Systematic Review and Meta-Analysis[J].Ann Clin Lab Sci,2020,50(2):161-171.[13]Fang T,Wang Y,Yin X,et al.Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer[J].J Immunol Res,2020,2020:9146042.[14]Zhang X,Wang D,Chen Z,et al.Red cell distribution width-to-lymphocyte ratio:A novel predictor for HBV-related liver cirrhosis[J].Medicine (Baltimore),2020,99(23):e20638.[15]Park JW,Chang HJ,Yeo HY,et al.The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters[J].British Journal of Cancer,2020,123(4):610-618.[16]van der Leun AM,Thommen DS,Schumacher TN.CD8(+)T cell states in human cancer:insights from single-cell analysis[J].Nat Rev Cancer,2020,20(4):218-232.[17]Bai Z,Zhou Y,Ye Z,et al.Tumor-Infiltrating Lymphocytes in Colorectal Cancer:The Fundamental Indication and Application on Immunotherapy[J].Frontiers In Immunology,2021,12:808964.[18]Falanga A,Schieppati F,Russo D.Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer[J].Semin Thromb Hemost,2015,41(7):756-64.[19]Lazar S,Goldfinger LE.Platelets and extracellular vesicles and their cross talk with cancer[J].Blood,2021,137(23):3192-3200.[20]de Gonzalo-Calvo D,deLuxán-Delgado B,Rodríguez-González S,et al.Interleukin 6,soluble tumor necrosis factor receptor I and red blood cell distribution width as biological markers of functional dependence in an elderly population:a translational approach[J].Cytokine,2012,58(2):193-198.[21]Hidalgo-Ríos S,Carrillo-García J,Moura DS,et al.Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib[J].Cancers (Basel),2022,14(17):4168.[22]Lu X,Huang X,Xue M,et al.Prognostic significance of increased preoperative red cell distribution width (RDW) and changes in RDW for colorectal cancer[J].Cancer Med,2023,12(12):13361-13373.[23]Fouda MS,Aljarwani RM,Aboul-Enein K,et al.Diagnostic performances of leucine-rich α-2-glycoprotein 1 and stem cell factor for diagnosis and follow-up of colorectal cancer[J].J Genet Eng Biotechnol,2021,19(1):17.
相似文献/References:
[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal
Cancer[J].Journal of Medical Information,2018,31(13):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]陈学敏,彭 琼.中性粒细胞与淋巴细胞比值联合癌胚抗原对结直肠癌早期诊断的研究[J].医学信息,2019,32(02):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
CHEN Xue-min,PENG Qiong.Early Diagnosis of Colorectal Cancer by Neutrophil-lymphocyte Ratio Combined with Carcinoembryonic Antigen[J].Journal of Medical Information,2019,32(13):75.[doi:10.3969/j.issn.1006-1959.2019.02.022]
[3]李在明,魏正强.外泌体在结直肠癌中的研究进展[J].医学信息,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
LI Zai-ming,WEI Zheng-qiang.Research Progress of Exosomes in Colorectal Cancer[J].Journal of Medical Information,2019,32(13):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
[4]周玲玲,鞠乐乐,颜 玉.结直肠癌患者手术前后血清IGF-1水平变化及临床价值分析[J].医学信息,2019,32(04):121.[doi:10.3969/j.issn.1006-1959.2019.04.039]
ZHOU Ling-ling,JU Le-le,YAN Yu.Analysis of Changes and Clinical Value of Serum IGF-1 Levels in Patients with Colorectal Cancer before and after Operation[J].Journal of Medical Information,2019,32(13):121.[doi:10.3969/j.issn.1006-1959.2019.04.039]
[5]陈小玉,白 鍊,贺春香.结直肠癌根治手术患者营养状况调查[J].医学信息,2019,32(05):83.[doi:10.3969/j.issn.1006-1959.2019.05.025]
CHEN Xiao-yu,BAI Lian,HE Chun-xiang.Investigation on Nutritional Status of Patients Undergoing Radical Surgery for Colorectal Cancer[J].Journal of Medical Information,2019,32(13):83.[doi:10.3969/j.issn.1006-1959.2019.05.025]
[6]李大略,赵资文,刘兆礼,等.加速康复外科对合并有糖尿病的结直肠癌患者术后炎症反应与营养代谢的影响[J].医学信息,2019,32(07):67.[doi:10.3969/j.issn.1006-1959.2019.07.021]
LI Da-lue,ZHAO Zi-wen,LIU Zhao-li,et al.Effect of Accelerated Rehabilitation Surgery on Postoperative Inflammatory Response and Nutrient Metabolism in Patients with Colorectal Cancer Complicated with Diabetes[J].Journal of Medical Information,2019,32(13):67.[doi:10.3969/j.issn.1006-1959.2019.07.021]
[7]王逸飞,王 志,左宏波,等.伊利替康联合替吉奥在晚期结直肠癌治疗的临床研究[J].医学信息,2019,32(07):158.[doi:10.3969/j.issn.1006-1959.2019.07.049]
WANG Yi-fei,WANG Zhi,ZUO Hong-bo,et al.Clinical Study of Irinotecan Combined with Tegafur,Gimeracil and Oteracil Porassium Capsulesin the Treatment of Advanced Colorectal Cancer[J].Journal of Medical Information,2019,32(13):158.[doi:10.3969/j.issn.1006-1959.2019.07.049]
[8]谢 勇,涂经楷,肖明盛,等.腹腔镜与传统开腹结直肠癌根治术手术效果对比[J].医学信息,2019,32(11):98.[doi:10.3969/j.issn.1006-1959.2019.11.026]
XIE Yong,TU Jing-kai,XIAO Ming-sheng,et al.Comparative of Laparoscopic and Traditional Open Radical Rectal Cancer Radical Operation[J].Journal of Medical Information,2019,32(13):98.[doi:10.3969/j.issn.1006-1959.2019.11.026]
[9]李莎莎,李 芳,王卫峰,等.地中海饮食与结直肠癌的相关研究[J].医学信息,2019,32(15):6.[doi:10.3969/j.issn.1006-1959.2019.15.003]
LI Sha-sha,LI Fang,WANG Wei-feng,et al.Correlation between Mediterranean Diet and Colorectal Cancer[J].Journal of Medical Information,2019,32(13):6.[doi:10.3969/j.issn.1006-1959.2019.15.003]
[10]孙 峰,鲍扬漪,朱 婷,等.晚期结直肠癌抗血管生成靶向治疗研究进展[J].医学信息,2019,32(17):1.[doi:10.3969/j.issn.1006-1959.2019.17.001]
SUN Feng,BAO Yang-yi,ZHU Ting,et al.Advances in Anti-angiogenesis Targeted Therapy for Advanced Colorectal Cancer[J].Journal of Medical Information,2019,32(13):1.[doi:10.3969/j.issn.1006-1959.2019.17.001]